Clyde Biosciences, A Leading Drug Toxicity Testing Company, Closes Series A Investment
April 13, 2015
Glasgow, United Kingdom, April 13th 2015 – Clyde Biosciences Ltd. (Clyde Biosciences) has announced a £2 million ‘Series A’ investment led by Epidarex Capital, a